# Efficacy and Safety of Early Initiation of Midodrine for Control and Prevention of Ascites and Its Related Complications in Acute-on-chronic Liver Failure.

> **NCT07422948** · NA · NOT_YET_RECRUITING · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 113 (estimated)

## Conditions studied

- Acute on Chronic Liver Failure

## Interventions

- **DRUG:** Midodrine
- **OTHER:** Standard Medical Treatment

## Key facts

- **NCT ID:** NCT07422948
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-05
- **Primary completion:** 2027-08-30
- **Final completion:** 2027-08-30
- **Target enrollment:** 113 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07422948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07422948, "Efficacy and Safety of Early Initiation of Midodrine for Control and Prevention of Ascites and Its Related Complications in Acute-on-chronic Liver Failure.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07422948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*